warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
| Harmonized routes |
|---|
| ORAL |
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Libido Stim Liquescence 3014 | openfda.brand_name | |
| generic name | LIBIDO STIM LIQUESCENCE | openfda.generic_name | |
| manufacturer name | Professional Complementary Health Formulas | openfda.manufacturer_name | |
| ndc | package | 63083-3014-4 | openfda.package_ndc |
| ndc | product | 63083-3014 | openfda.product_ndc |
| ndc11 | package | 63083301404 | derived:openfda.package_ndc |
| spl id | ba57f830-64e2-4b2c-a4d9-4c7c13015946 | id | |
| spl set id | 3d59b77d-817b-4021-a6dd-75d3b4b60866 | set_id | |
| unii | MN0RX54EQA | openfda.unii | |
| unii | J7WWH9M8QS | openfda.unii | |
| unii | Q74T35078H | openfda.unii | |
| unii | 1TH8Q20J0U | openfda.unii | |
| unii | PDC6A3C0OX | openfda.unii | |
| unii | 66LZN1C747 | openfda.unii | |
| unii | 9679TC07X4 | openfda.unii | |
| unii | 451W47IQ8X | openfda.unii | |
| unii | 1NM3M2487K | openfda.unii | |
| unii | PR4RXL6G2H | openfda.unii | |
| unii | 24K790T39B | openfda.unii | |
| unii | Q59QU6N72Q | openfda.unii | |
| unii | 433OSF3U8A | openfda.unii | |
| unii | 91O4LML611 | openfda.unii | |
| unii | 812R0W1I3K | openfda.unii | |
| unii | CLF5YFS11O | openfda.unii | |
| unii | 043IPI2M0K | openfda.unii | |
| unii | 2Y49VWD90Q | openfda.unii | |
| unii | H6241UJ22B | openfda.unii |
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse event summaries are temporarily unavailable. Other product information remains available.